Related Experiment Videos

Spontaneous degenerative polyarthritis in male New Zealand black/KN mice

K Nakamura1, S Kashiwazaki, K Takagishi

  • 1Department of Biochemistry, Kitasato University School of Medicine, Kanagawa, Japan.

Arthritis and Rheumatism
|February 1, 1991
PubMed

Insights

Male New Zealand black/KN (NZB/KN) mice spontaneously develop polyarthritis, a joint disease characterized by autoantibody deposits. This transferable condition offers a valuable model for studying rheumatoid arthritis pathogenesis and treatment strategies.

Area of Science:

  • Immunology
  • Rheumatology
  • Animal Models

Background:

  • Rheumatoid arthritis (RA) is a chronic autoimmune disease causing joint inflammation and damage.
  • Existing animal models for RA research have limitations, such as rapid mortality or lack of specific disease characteristics.

Purpose of the Study:

  • To characterize a spontaneous polyarthritis model in male New Zealand black/KN (NZB/KN) mice.
  • To evaluate the utility of this model for investigating rheumatoid arthritis pathogenesis and therapeutic interventions.

Main Methods:

  • Histopathologic examination and radiographic analysis of joints in NZB/KN mice.
  • Detection of autoantibodies, rheumatoid factor, anti-type II collagen antibodies, and serum oxidation activity.
  • Spleen cell transfer experiments to assess disease transmissibility.

Main Results:

  • Male NZB/KN mice aged 2 months onwards exhibited degenerative polyarthritis in paws.
  • Autoantibody deposits were found on collagen fibers, chondrocytes, and epidermal cells.
  • Increased rheumatoid factor, anti-type II collagen antibodies, and serum oxidation activity were observed. Disease was transferable via spleen cells.

Conclusions:

  • NZB/KN mice provide a novel, spontaneous animal model for polyarthritis.
  • This model is suitable for studying rheumatoid arthritis pathogenesis due to its specific joint pathology and longer survival compared to other models like MRL/lpr mice.
  • The model facilitates the evaluation of new treatment strategies for rheumatoid arthritis.

Related Concept Videos